Henoch-Schönlein purpura epidemiology and demographics

	Henoch-Schönlein purpura Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Henoch-Schönlein purpura from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Henoch-Schönlein purpura epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Henoch-Schönlein purpura epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Henoch-Schönlein purpura epidemiology and demographics
CDC on Henoch-Schönlein purpura epidemiology and demographics
Henoch-Schönlein purpura epidemiology and demographics in the news
Blogs on Henoch-Schönlein purpura epidemiology and demographics
Directions to Hospitals Treating Henoch-Schönlein purpura
Risk calculators and risk factors for Henoch-Schönlein purpura epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview[edit | edit source]

The incidence of HSP is approximately 6-20 cases per 100,000 individuals. The prevalence of HSP is more in children of 4-6 years age group. HSP usually affects Caucasians than any other ethnic groups. Males are more commonly affected by HSP than females. The Male to female ratio is approximately 1.5-2:1.

Epidemiology and demgraphics[edit | edit source]

Epidemiology and demgraphics of HSP:^[1]^[2]

Incidence[edit | edit source]

The incidence of HSP is approximately 6-20 cases per 100,000 individuals.

Age[edit | edit source]

The prevalence of HSP is more in children of 4-6 years age group.

Race[edit | edit source]

HSP usually affects Caucasians than any other ethnic groups.

Gender[edit | edit source]

Males are more commonly affected by HSP than females. The Male to female ratio is approximately 1.5-2:1.

References[edit | edit source]

↑ Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB (February 2014). "Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura". J. Korean Med. Sci. 29 (2): 198–203. doi:10.3346/jkms.2014.29.2.198. PMC 3923997. PMID 24550645.
↑ Schmoldt A, Benthe HF, Haberland G, Sinelnikova EM, Dvoretskova TV, Kagan ZS, Horty JF, Geering K, Becker M, Beglinger R, Stauffer UG (September 1975). "Digitoxin metabolism by rat liver microsomes". Biochem. Pharmacol. 24 (17): 1639–41. PMID 10.

Template:WH Template:WS

[pmid24550645-1] Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, Lee SK, Park YB (February 2014). "Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura". J. Korean Med. Sci. 29 (2): 198–203. doi:10.3346/jkms.2014.29.2.198. PMC 3923997. PMID 24550645.

[pmid10-2] Schmoldt A, Benthe HF, Haberland G, Sinelnikova EM, Dvoretskova TV, Kagan ZS, Horty JF, Geering K, Becker M, Beglinger R, Stauffer UG (September 1975). "Digitoxin metabolism by rat liver microsomes". Biochem. Pharmacol. 24 (17): 1639–41. PMID 10.

[1]

[2]